Study: Phenols in purple corn fight diabetes, obesity, inflammation in mouse cells

April 15, 2019

CHAMPAIGN, Ill. -- Scientists at the University of Illinois have developed new hybrids of purple corn containing different combinations of phytochemicals that may fight obesity, inflammation and diabetes, a new study in mice indicates.

The pericarp - or outer layer - of purple and other brightly colored corn kernels also may provide an alternative source of colorants for food products, giving corn producers another value-added product from their crop, said the U. of I. team led by food science professor Elvira Gonzalez de Mejia and crop sciences professor John Juvik. They published their findings recently in the journal Food Chemistry.

From a strain of maize called Apache Red, Juvik's team bred 20 genetic varieties of purple corn, each with a unique combination of anthocyanins, the nutritious, natural pigments that give the pericarp its vibrant color.

Widely found in plant tissues, phenolic compounds tend to be aromatic and contribute to the color, flavor and acidity of fruits. Anthocyanins are one class of phenols, and studies have associated the consumption of anthocyanin-rich foods with reduced risks of cardiovascular disease, Type 2 diabetes and certain types of cancer.

Using pressurized water, postdoctoral researcher and study co-author Diego Luna-Vital extracted the anthocyanins from the pericarp of the corn kernels, creating anthocyanin-rich water extracts that were then freeze-dried. While analyses of the extracts showed that the pericarp is an abundant source of anthocyanins and phenolic compounds, the concentration varied significantly among the varieties.

To examine the impact of anthocyanins on obesity-induced inflammation, then-graduate student and first author of the study Qiaozhi Zhang combined fat cells - called adipocytes - from mice with large immune cells called macrophages.

The mouse cell models in the study simulated those of obese people with high concentrations of lipids and inflammation in their cells, or healthy individuals who regularly eat plants containing phenolic compounds, de Mejia said. "So these are very real models that can be translated into in vivo studies with humans or animals."

"We evaluated some very specific biomarkers already known to be related to inflammation and adipogenesis, which is the conversion of pre-adipocytes to mature adipocytes that accumulate fat," Luna-Vital said.

They observed that the phenolic compounds in the extracts altered the cells' development, reducing the adipocytes' fat content from 8%-56%, depending on the differing phenols used.

To study the compounds' impact on insulin resistance, the metabolic dysfunction associated with diabetes, the scientists used a cell-signaling protein to induce insulin resistance in the mouse fat cells, then treated the cells with the anthocyanin compounds and monitored their glucose uptake.

A key marker of insulin resistance decreased by 29%-64%, they found, and the cells' glucose uptake decreased by 30%-139%, depending on the chemical composition of the anthocyanins used.

"We observed very important changes in molecules that reduced oxidative stress and inflammation in the insulin-resistant adipocytes," Luna-Vital said. "We also found important changes in pro-inflammatory molecules in the immune cells."

The findings suggested that different levels and chemical compositions of these phenolic compounds might prevent obesity or improve the insulin profile of people who are obese, Luna-Vital said.

The smaller phenols such as quercetin, luteolin and rutin - which are present in many plant foods - played key roles in reducing some of the obesity, inflammation and some markers of Type 2 diabetes, de Mejia said. "While others, such as vanillic and protocatechuic acid, decreased the potential conversion of pre-adipocytes to adipocytes."

She cautioned, though, that "it's very important to note that it's not just one or two compounds, but the combinations of phenolics" working together that were responsible for the beneficial effects.

Graduate student and study co-author Laura Chatham currently is performing genomic selection to identify the DNA markers associated with the most promising health effects in order to breed corn hybrids with those properties, Juvik said.

In addition to its health-promoting properties, the pericarp of red, purple and other brightly hued corn could serve as natural pigments for the food industry, satisfying strong consumer demand for alternatives to synthetic dyes, Juvik said.

"We calculated that all of the red dye No. 40 - one of the major dyes used in the U.S. - could be replaced with the pigment derived from about 600,000 acres of corn," Juvik said. "And we could produce the anthocyanin-rich pericarp in sufficient quantities for manufacturers to add it to beverages or special products with pharmaceutical properties."

Another advantage to dried corn is that it's shelf-stable, providing an economical substitute for the perishable fruits and vegetables that manufacturers also currently use to color many foods and beverages, he said.

"The advantage to using water to extract the anthocyanins from the pericarp is that it's the most simple, straightforward and inexpensive way for industry to remove these compounds, compared with other extraction protocols that are complicated and more expensive," Juvik said.
-end-
Water extraction is also a "green" process, compliant with environmental and food and drug regulations, said de Mejia, also the director of the Division of Nutritional Sciences.

U. of I. agricultural and biological engineering professors Vijay Singh and Deepak Kumar, and undergraduate student Subhiksha Chandrasekaran co-wrote the study, along with Tianyi Tao of Zhejiang University, China.

The research was supported by a U.S. Department of Agriculture National Institute of Food and Agriculture grant.

University of Illinois at Urbana-Champaign

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.